Literature DB >> 1154285

Inhibitory effect of corticoids on the proliferative pattern in mouse palatal processes.

R Jelínek, M Dostál.   

Abstract

The formation of the secondary palate in mice is accompanied by intensive mitotic activity, which is mainly concentrated at the medial edges of the palatal processes. In control H-Velaz randombred fetuses the mitotic activity culminated approximately 24 h before palatal-shelf horizontalization, so that the period of intensive cell proliferation coincided with the period when cleft palate could be induced by cortisone administration. Effects of teratogenic doses of corticoids, injected directly into amniotic sac of embryos on day 13 (0.3 mg hydrocortisone) or im to pregnant females on day 12 (7.5 mg cortisone acetate), on the proliferative peak in palatal processes were studied using intraamniotic injection of colchicine. Counts of colchicine-blocked mitoses in histological serial sections revealed both a significant decrease in overall mitotic density and a posterior shift of the proliferative peak in the palatal processes of fetuses treated with doses of corticoids producing cleft palate.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 1154285     DOI: 10.1002/tera.1420110208

Source DB:  PubMed          Journal:  Teratology        ISSN: 0040-3709


  3 in total

1.  Long bone growth during prolonged intermittent corticosteroid treatment and subsequent rehabilitation.

Authors:  M Silbermann; S Levitan; U Kleinhaus; S Finkelbrand
Journal:  Cell Tissue Res       Date:  1979-09-02       Impact factor: 5.249

2.  The effects of the glucocorticoid, dexamethasone, on the development of the Drosophila embryo.

Authors:  Teresa Ruth Strecker; Peng Li; Sean Austin McGhee; Debby Ham; Su Kyong Smith; Jennifer Ann Schreck; Sue Jung Youn; Philantha Sue-Hwa Kon
Journal:  Rouxs Arch Dev Biol       Date:  1995-06

Review 3.  Receptor-dependent mechanisms of glucocorticoid and dioxin-induced cleft palate.

Authors:  R M Pratt
Journal:  Environ Health Perspect       Date:  1985-09       Impact factor: 9.031

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.